Sens Stocktwits – Senseonics Holdings, Inc. is a medical technology company, which engages in the design, development and commercialization of glucose monitoring solutions. It comprises the Ever-sense CGM (continuous glucose monitoring) brand in the form of sensors, smart transmitters, and mobile apps. It was founded on June 26, 2014 and is headquartered in Germantown, MD.
Table of Contents
About Sens Senseonics Holdings Company
“SENS,” Which Stands for Senseonics Holdings, Inc., is a medical technology company and develops continuous glucose monitoring (CGM) systems mainly in the United States. Led by its flagship product, the Eversense CGM System, Senseonics is on a mission to turn the many millions of adjustments and interventions needed every hour in diabetes care into data-driven decisions. Though for different reasons Senseonics is often referenced as a marquee example of innovation in the medical device industry, particularly in diabetes care.
StockTwits is the perfect platform for traders, investors, and financial enthusiasts to come together and discuss market news, stock analysis or keep updated on the sentiment by other traders regarding stocks as well as cryptocurrencies. StockTwits is home to over millions of active investors; investors use StockTwits to monitor the stocks that they hold and watch the stock market in real-time, including, timely tagged ticker streams.
They have created a unique SENS StockTwits where investors can discuss Senseonics Holdings, Inc. SENS stock. This feed enables investors to get a better read on what is happening at SENS and view the most current market sentiment in real time, as well as understand the investment context for recent events related to the company.
Key Points
Live Quotes Live SENS Stock Price: For any investor, his stock moves to the up side or at down which describes the investor sentiment. This real-time sentiment could be valuable to traders for the market psychology.
FDA approvals: Investments, product and financial updates. Whenever an announcement is made, StockTwits users will discuss the news and how it could affect SENS stock. For example, finding a proficiency in FDA approval updates or any product advancements for the Eversense system could just be what his team need to know about as those type of conversations are vital to the company’s growth prospects.
Messages and StockTwits: Members on StockTwits post technical analysis about SENS shares like moving averages, fundamental reports stock chart patterns, historical sensex etc. This is popular among short-term investors and day traders in general because this technical analysis often sets the tone of a trade.
SENS Discussions: As with the vast majority of biotech and small-cap stocks, SENS is a bit of a talker on feeds. The validity of potential buyouts or partnerships is a frequent topic of conversation, as are how macro conditions might affect SENS stock down the road. There is much speculation about what future FDA approvals and technological advances we might see in the treatment of diabetes.
Community Sentiments and Interaction: Sens StockTwits sentiment community. Yup, those kinds of things are posted on the SENS feed. Investors post and ask for suggestions and details about their investment style that works for them. The idea is to create a kind of community hub where fresh traders and established gamblers can come together to discuss what the best plans are for SENS stock and how well it seems to be going at that time.
Sens Stock Data
MARKET CAP: $217.93M
FLOAT: $1.46M
INDUSTRY: Electronic Components
SECTOR: Electronic Technology
WEBSITE: https://www.senseonics.com/
COUNTRY: United States of America
CITY: GermanTown, MaryLand
Risks and Volatility SENS StockTwits
The reason the stock has garnered attention on StockTwits is because of its unique position in the medical technology, specifically related to diabetes long-term continuous glucose monitoring (CGM) system can be a gamechanger in this space where technological advancements are being called forth due to the increase in diabetes cases globally. On top of this, small-cap stocks like SENS are notorious for capturing the attention of retail traders since they can deliver enormous returns (and losses), which is why it has been such a popular topic on StockTwits.
While many StockTwits users are bullish on Senseonics, the stock does present risks. Senseonics is a company that is going through the same struggles as any other smaller biotech company, such as delays in FDA approvals for its product pipeline and competition from other diabetes monitoring technologies granted, and also faces potential revenue fluctuations. In fact, warnings from veteran traders that these small-cap medical device stocks tend to be highly volatile populate StockTwits discussions.
Similar Companys
Dexcom Inc [DXCM]
Medtronic Plc [MDT]
Abbott Laboratories [ABT]
Nemaura Medical [NMRD]
Insulet Corporation [PODD]
Dexcom Inc (DXCM) Statistics & Alternative Data 2024
Published August 30 2010 DexCom, Inc. is a medical device company that develops, manufactures and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes. Products Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API and Dexcom ONE. It was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Medtronic Plc (MDT) Statistics & Alternative Data 2024
Medtronic Plc is a medical technology company, which engages in the manufacture, development, sales and distribution of device-based medical therapies and services. The Medical Surgical Portfolio, Cardiovascular Portfolio, Diabetes Operating Unit segments and Neuroscience Portfolio. Cardiovascular Portfolio segment includes products for the treatment, management and diagnosis of cardiovascular disease and cardiac rhythm disorders.
The Neuroscience Portfolio includes cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio consists of surgical innovations and divisions for respiratory, gastrointestinal, and renal. The Diabetes Group segment provides insulin pumps, continuous glucose monitoring systems, and insulin pump consumables It was established in 1949 with its headquarters located Dublin, Ireland.
Abbott Laboratories (ABT) Statistics & Alternative Data 2024
Abbott Laboratories manufactures and sells healthcare products. Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Medical Devices. We calculate our financial projections assuming that all markets within the Established Pharmaceutical Products segment include based sales. The Diagnostic Products segment sells diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites.
The sales of adult and pediatric nutritional products around the globe is serviced by the Nutritional Products segment. The Medical Devices segment of the company develops various electro-physiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products to aid patients in managing their glucose levels, as well as neuromodulation devices to help manage chronic pain and movement disorders. It was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Nemaura Medical (NMRD) Statistics & Alternative Data 2024
Nemaura Medical, Inc. is a holding company It operates in medical device research. The company has developed an adhesive skin-patch-based continuous glucose monitoring device called sugar BEAT. Disposable adhesive skin-patch with a rechargeable, water-resistant wireless transmitter is part of the sugar BEAT which transmits glucose readings every five minutes using a mobile app. It was founded by Dewan Fazlul Hoque Chowdhury on December 24, 2013 and is headquartered in New York, NY.
Insulet Corporation (PODD) Statistics & Alternative Data 2024
Insulet Corp. is engaged in the development, manufacture and marketing of an insulin infusion system for people with insulin-dependent diabetes. The latest of the three channels to launch is a direct-to-consumer online mail-order pharmacy that offers extensive virtual care management in diabetes, as well as insulin pumps and pump supplies. It had been founded by John L. Brooks III and John T. Garibotto in 7/2000 and is headquartered in Acton, MA.
Conclusion
In the world of investing, such as day trading or swing trading feeds like SENS StockTwits offer insight, news, and more for Senseonics Holdings, Inc. Whether you’re a day trader chasing the charts, investor keeping an ear to the ground for regulatory news, or someone who just likes following along with new diabetes technology, the SENS StockTwits community holds value worth checking out. But, like with any social media platform, investors should do their own due diligence and take the conversations with a grain of salt especially when it comes to speculative stocks.
